HR7863

HR7863, the "Promoting Fairness for Medicare Providers Act of 2026," amends sections 1832 and 1833 of the Social Security Act to specifically align Medicare payments for certain high-cost surgical procedures when furnished in office-based facilities. Effective for procedures performed in 2027 and subsequent years, the bill mandates that Medicare payments for these facility services will be 80 percent of the payment amount determined under section 1834(bb). This change directly addresses a historical disparity where office-based facilities received lower reimbursement for procedures involving high-cost supplies compared to hospital outpatient departments, making these procedures more financially attractive for office-based settings. The money trail for this legislation is direct: increased Medicare payments flow from the Centers for Medicare & Medicaid Services (CMS) to eligible office-based facilities. This means a direct increase in revenue for companies that own, operate, or manage these outpatient surgical centers. The mechanism is a regulatory change in reimbursement, not a direct appropriation, but it effectively increases the total addressable market and profitability for specific procedures within these facilities. Companies providing staffing, equipment, or management services to these facilities will also benefit indirectly from the increased financial health of their clients. Historically, legislative actions that increase Medicare reimbursement for specific services have led to immediate positive market reactions for affected providers. For example, when the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015 reformed physician payment, healthcare service providers saw sustained growth. While not directly comparable in scope, targeted reimbursement increases consistently boost the bottom line of the specific service providers. The passage of the Ambulatory Surgical Center (ASC) Payment Reform in 2008, which increased payments for certain procedures in ASCs, led to a significant expansion of the ASC market and increased valuations for companies operating in that space over the subsequent years. Specific winners include companies with significant exposure to outpatient surgical centers and diagnostic services. $AMN Healthcare Services, a major staffing provider for these facilities, will benefit from increased demand and profitability for its clients. Hospital operators with outpatient divisions, such as $THC (Tenet Healthcare), $HCA (HCA Healthcare), and $UHS (Universal Health Services), will see enhanced revenue from their office-based surgical offerings. Pure-play ambulatory surgery center operators like $SURG (Surgery Partners) are direct beneficiaries. There are no clear losers from this bill, as it only increases reimbursement for a specific subset of providers without reducing payments elsewhere. This bill has been referred to the Committee on Energy and Commerce and the Committee on Ways and Means. The sponsorship by Rep. Bilirakis (R-FL), a senior member of the Energy and Commerce Committee, along with bipartisan cosponsors, indicates moderate legislative momentum. The next steps involve committee hearings and potential markups. If it passes committee, it moves to a floor vote in the House, then to the Senate. The effective date of 2027 provides a clear timeline for implementation, allowing companies to strategically plan for increased revenue streams.